Background P = 0.013. This association remained significant after adjustment for potential confounders. Similarly, when modeled as a log₂-transformed continuous variable, LRG1 levels were also significantly associated with overall survival (HR per doubling = 5.82 95% CI: 1.35–25.13; P = 0.018). Conclusions: LRG1 significantly predicted three-year overall survival in patients with metastatic breast cancer, supporting its potential as a prognostic biomarker.
Muendlein et al. (Thu,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: